Diabetes Mellitus in Pediatric Patients with Cystic Fibrosis
Abstract
Introduction: Cystic Fibrosis (CF) is a hereditary recessive disease that affects several organs, mainly within the respiratory and digestive systems. Cystic Fibrosis Related Diabetes (CFRD) is one of its main complications.
Objectives: To study the specific complications of pediatric patients suffering from CFRD and how they affect a patient’s quality of life. To compare the mortality rates of pediatric patients with CF and with CFRD. To highlight the importance of nurses in the management of pediatric patients with CFRD.
Methodology: A systematic bibliographic review was conducted. We included studies, in English and Spanish, published over the last 10 years, which analysed a population aged between 0 and 9 years old with CF and/or CFRD.
Results: Four databases were used for the systematic search. We analysed 10 articles to address the objectives.
Conclusions: The complications caused by CFRD and the care that patients require affect the patient’s quality of life. Progress both with diagnosis and with treatment has improved the quality of life of patients, and has contributed to reductions in the difference between the mortality rates of patients with CF and without CFRD. Nurses who care for children with CFRD are essential as an information resource for patients and their families. Nurses must convey the importance of therapeutic adherence to achieve a better quality of life.
Downloads
References
Las ER [Internet]. CRE Enfermedades Raras. Centro de Referencia Estatal de Atención a Personas con Enfermedades Raras y sus Familias de Burgos. 2015. Available from: http://www.creenfermedadesraras.es/creer_01/er_mh/er/index.htm
¿Qué es la Fibrosis Quística? [Internet]. Federación Española de Fibrosis Quística. 2015. Available from: https://fibrosisquistica.org/?pagina=fibrosi
Escobar Héctor, Sojo A. Fibrosis quística: protocolos diagnósticos y terapéuticos en pediatría. :99–110. Available from: http://www.aeped.es/sites/default/files/documentos/10-FQ.pdf
Omneda. Fibrosis quística Síntomas: Pulmones, Páncreas, Aparato digestivo, Bilis [Internet]. Onmeda. 2017. Available from: http://www.onmeda.es/enfermedades/fibrosis_quistica-sintomas-1568-4
Acuña Quirós MD, Araque González S, Azxorra Liñero I, Castillo Calcerrada J, Costilla García A, Girón Moreno R, et al. Guía de apoyo y cuidados para enfermos y familiares con Fibrosis Quística. Lo que necesitan el paciente y su familia. 2017.
Tratamiento [Internet]. Federación Española de Fibrosis Quística. 2015. Available from: https://fibrosisquistica.org/?pagina=vivir&vivir=tratamiento
Sánchez-Solis de querol M, Baquero Mochales F, Cantón Moreno R, Gartner Tizzano S, Cobos Barroso N, Salcedo Posadas A, et al. Los tres pilares del tratamiento en fibrosis quística. Federación Española contra la Fibosis Quística. Valencia; 2014.
Diagnóstico [Internet]. Federación Española de Fibrosis Quística. 2015. Available from: https://fibrosisquistica.org/?pagina=vivir&vivir=diagnostico
SaCyL. Programa de detección precoz de enfermedades congénitas [Internet]. Junta de Castilla y León. 2018. Available from: http://www.saludcastillayleon.es/profesionales/es/programas-guias-clinicas/programas-salud/programa-deteccion-precoz-enfermedades-congenitas
Escobar Castro H, Sojo Aguirre A, Gil Ortega D, Nadal Ortega JM. Fibrosis quística. Asoc Española Pediatría [Internet]. 2010;77–84. Available from: http://www.aeped.es/sites/default/files/documentos/fquistica.pdf
Alonso M, Barrio R, Martín-Frías M, Álvare MÁ, Yelmo R, Martínez E, et al. Lo que debes saber sobre la Diabetes Relacionada con la Fibrosis Quística (DRFQ) [Internet]. Madrid: Federación Española de Fibrosis Quística; 2014. Available from: https://www.seep.es/images/site/gruposTrabajo/enlaces/Diabetes_en_Fibrosis_Quistica-RB.pdf
Brunzell C, S. Hardin D, Kogler A, Moran A, Schindler T. El manejo de la Diabetes Relacionada con la Fibrosis Quística (CFRD): Una guía instructiva para los pacientes y sus familias [Internet]. 6a. Bethesda: Cystic Fibrosis Foundation; 2015. Available from: https://www.cff.org/Spanish-Language-CFRD-Manual.pdf
Laguna TA, Nathan BM, Moran A. Managing diabetes in cystic fibrosis. Diabetes, Obes Metab. 2010;12:858–64.
O’Riordan SMP, Robinson PD, Donaghue KC, Moran A. Management of cystic fibrosis-related diabetes in children and adolescent. Pediatr Diabetes. 2009;10:43–50.
Ode KL, Moran A. New insights into cystic fibrosis-related diabetes in children. Lancet Diabetes Endocrinol. 2013;1:52–8.
Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, et al. Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes. Diabetes Care. 2010;33:2697–708.
Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing Cystic Fibrosis. Am J Respir Crit Care Med. 2011;183:1463–71.
Kelly A, Moran A. Update on cystic fibrosis-related diabetes. J Cyst Fibros. 2013;12:318–31.
Chamnan P, Shine BSF, Aworth CS, Bilton D, Adler AI. Diabetes as a Determinant of Mortality in Cystic Fibrosis. Diabetes Care. 2010;33:311–6.
O’Riordan SMP, Dattani MT, Hindmarsh PC. Cystic Fibrosis-Related Diabetes in Childhood. Horm Res Oaediatrics. 2010;73:15–24.
Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic Fibrosis-Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality. Diabetes Care. 2009;32:1626–31.
Illán Noguera CR, Álvarez Martínez M del C, Martínez Rabadán M, Pina Díaz LM, Guillén Pérez F, Bernal Barquero M, et al. Cuidados de enfermería y orientación en niños y adolescentes con fibrosis quística: una revisión bibliográfica. Rev Enfermería Docente. 2014;102:67–74.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
